Patient Guide: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 17 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06768671
Status: 🟢 Enrolling Now
Condition: Hidradenitis Suppurativa
Phase: PHASE3

Where You Can Participate

This study is available at 17 locations across the country.

Top locations include:
  • • North Little Rock, Arkansas
  • • Hollywood, California
  • • Stanford, California
  • • And 14 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) - Join Clinical Trial NCTNCT06768671

How to Join This Clinical Trial - NCTNCT06768671

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hidradenitis Suppurativa. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hidradenitis Suppurativa. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hidradenitis Suppurativa
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06768671 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 17 locations. Find a study site near you:

Clinical Research Site

North Little Rock, Arkansas 72117 - United States

Status: RECRUITING

Clinical Research Site

Hollywood, California 33021 - United States

Status: RECRUITING

Clinical Research Site

Stanford, California 94304 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20010 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: RECRUITING

Clinical Research Site

Macon, Georgia 31217 - United States

Status: RECRUITING

Clinical Research Site

Sandy Springs, Georgia 30328 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Indiana 47201 - United States

Status: RECRUITING

Clinical Research Site

Murray, Kentucky 42071 - United States

Status: RECRUITING

And 7 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hidradenitis Suppurativa:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships